Frontiers in Psychiatry (Jun 2024)

Changes in tryptophan breakdown associated with response to multimodal treatment in depression

  • Eva Z. Reininghaus,
  • Melanie Lenger,
  • Elena M. D. Schönthaler,
  • Frederike T. Fellendorf,
  • Tatjana Stross,
  • Markus Schwarz,
  • Natalie Moll,
  • Bernd Reininghaus,
  • Nina Dalkner

DOI
https://doi.org/10.3389/fpsyt.2024.1380620
Journal volume & issue
Vol. 15

Abstract

Read online

BackgroundResearch on depression showed that dysregulations in tryptophan (TRP), kynurenine (KYN), and its KYN pathway metabolites are key aspects in the development and maintenance of depressive symptoms. In our previous reports, we described sex-specific changes in TRP breakdown as well as changes in KYN and KYN/TRP in association with treatment response and inflammatory and metabolic parameters. However, results of treatment effects on KYN pathway metabolites as well as how pathway changes are related to treatment response remain sparse.ObjectiveWe investigated potential changes of KYN and KYN pathway metabolites in association with therapeutic response of individuals with depression during a six-week multimodal psychiatric rehabilitation program.Methods87 participants were divided into treatment responders and non-responders (48 responders, 39 non-responders; 38 male, 49 female; Mage = 51.09; SDage = 7.70) using scores of psychological questionnaires. KYN pathway metabolites serum concentrations as well as their ratios were collected using high performance liquid chromatography. Changes over time (time of admission (t1) vs. time of discharge (t2)) were calculated using repeated measure analyses of (co)variance.ResultsNon-responders exhibited higher levels of 3-Hydroxyanthralinic acid (3-HAA), nicotinic acid (NA), and 3-HAA/KYN, independently of measurement time. NA levels decreased, while 3-HAA levels increased over time in both groups, independently of treatment response. 3-HK/KYN levels decreased, while KYN levels increased in non-responders, but not in responders over time.DiscussionThe results indicate that some compounds of the KYN pathway metabolites can be altered through multimodal long-term interventions in association with treatment response. Especially the pathway degrading KYN further down to 3-HAA and 3-HK/KYN might be decisive for treatment response in depression.

Keywords